Mylab bags CDSCO approval for PathoDetect HSV Type 1& 2 Detection kit
According to Hasmukh Rawal, Co-founder and MD, Mylab Discovery Solutions, herpes simplex virus detection test will aid in the effective and early diagnosis of the infection which will help patients with the proper management of the disease
Mylab Discovery Solutions has received CDSCO approval for PathoDetect HSV Type 1& 2 Detection kit, a multiplex real-time PCR test that detects and differentiates herpes simplex virus type I (HSV-l) and type 2 (HSV-2) in a single tube.
Speaking about the launch of ‘PathoDetect HSV Type 1 & 2 Detection Test’, Hasmukh Rawal, Co-founder and MD, Mylab Discovery Solutions said, “HSV is a highly contagious virus that can affect a person’s physical, emotional, and psychological health. Symptoms of herpes can be misinterpreted or confused among other diseases. For this reason, the introduction of a fast and accurate molecular test that distinguishes between HSV 1 and HSV 2 will be an important diagnostic tool. We are confident that our HSV Detection test will aid in the effective and early diagnosis of the infection which will help patients with proper management of the disease and lower the risk of transmission.”